Clinical Trials on OTCD in New Zealand

Total 13 results

University of Pennsylvania
National Institute of Mental Health (NIMH); New York University; New York State... and other collaborators

Recruiting

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

OCD

United States
New York State Psychiatric Institute

Completed

Feasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCD (nOCD)

Obsessive Compulsive Disorder (OCD)

United States
Weill Medical College of Cornell University
The New Venture Fund / Foundation for OCD Research; The Wellcome Leap Fund

Recruiting

Accelerated TMS for Depression and OCD

Depression | OCD

United States
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Recruiting

Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder

Obsessive Compulsive Disorder (OCD)

United States
New York State Psychiatric Institute

Completed

Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder (OCD)

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder

Obsessive-compulsive Disorder | Ocd

United States
Jamaica Hospital Medical Center
Bristol-Myers Squibb; Department of Psychiatry, Jamaica Hospital Medical Center and other collaborators

Completed

Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)

Obsessive Compulsive Disorder | Schizophrenia OCD

United States
Ultragenyx Pharmaceutical Inc

Completed

Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset Ornithine Transcarbamylase (OTC) Deficiency (CAPtivate)

Ornithine Transcarbamylase (OTC) Deficiency

United Kingdom, United States, Canada, Spain
Ultragenyx Pharmaceutical Inc

Active, not recruiting

Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency (CAPtivate)

Ornithine Transcarbamylase (OTC) Deficiency

Canada, United States, France, Spain, United Kingdom
Ochsner Health System

Withdrawn

Transcranial Doppler(TCD) Evaluation of High Intensity Transient Signals and Carotid Disease (TCD)

TCD | Symptomatic Carotid Stenosis | Asymptomatic Carotid Stenosis | HITS

United States
Vericel Corporation

Recruiting

A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee (PEAK)

Chondral Defect | Articular Cartilage Disorder of Knee | Articular Cartilage Defect | Osteochondritis Dissecans (OCD)

United States
Novartis Pharmaceuticals

Terminated

Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy

Patient Diagnosed With OCD and Resistant to SSRI Treatment | Failed SSRI Over 12 Weeks at Appropriate Doses

Germany, Switzerland, Bulgaria, United States, Czech Republic
Ultragenyx Pharmaceutical Inc

Recruiting

Clinical Study of DTX301 AAV- Mediated Gene Transfer for Ornithine Transcarbamylase(OTC) Deficiency

OTC Deficiency

United States, Portugal, Australia, Italy, Spain, United Kingdom, Japan, Canada, Germany, France, Argentina, Netherlands, Brazil

Clinical Trials on OTCD in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations